ArticleLeukemia2022
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.
Satoko Kakiuchi-Kiyota et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it
ArticleLeukemia2022
Satoko Kakiuchi-Kiyota et al.PubMed ↗Publisher ↗
No numbers read from the abstract.